Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1082-1087

  Canda, Aras Emre ^a   Sokmen, Selman ^a   Terzi, Cem ^a   Arslan, Cigdem ^a   Oztop, Ilhan ^a   Karabulut, Bulent ^b   Ozzeybek, Deniz ^a   Sarioglu, Sulen ^a   Fuzun, Mehmet ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD TOXICITY; CARCINOMATOSIS; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OPERATION DURATION; PERITONEAL CARCINOMATOSIS; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; HYPERTHERMIA, INDUCED; KIDNEY DISEASES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84875228040     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2853-x     Document Type: Conference Paper

References (25)

1. R Younan S Kusamura D Baratti AS Cloutier M Deraco 2008 Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy J Surg Oncol. 98 4 253 257 18726887 10.1002/jso.21057
2. National Cancer Institute (NCI)/National Institute of Health (NIH). Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/welcome-to-ctcae.htm. Accessed 30 April 2012.
3. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Boston: Kluwer Academic; 1996:359-74.
4. P Jacquet PH Sugarbaker 1996 Current methodologies for clinical assessment of patients with peritoneal carcinomatosis J Exp Clin Cancer Res. 15 49 58
5. P Shen J Hawksworth J Lovato BW Loggie KR Geisinger RA Fleming EA Levine 2004 Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma Ann Surg Oncol. 11 178 186 14761921 10.1245/ASO.2004.05.009
6. EA Levine JH Stewart GB Russell KR Geisinger BL Loggie P Shen 2007 Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures J Am Coll Surg. 204 943 945 17481516 10.1016/j.jamcollsurg.2006.12.048
7. VJ Verwaal S van Ruth A Witkamp H Boot G van Slooten FA Zoetmulder 2005 Long-term survival of peritoneal carcinomatosis of colorectal origin Ann Surg Oncol. 12 65 71 15827780 10.1007/s10434-004-1167-z
8. RG Da Silva PH Sugarbaker 2006 Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer J Am Coll Surg. 203 878 886 17116556 10.1016/j.jamcollsurg.2006.08.024
9. TD Yan DL Morris 2008 Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg. 248 829 835 18948811
10. O Glehen F Kwiatkowski PH Sugarbaker D Elias EA Levine M De Simone R Barone Y Yonemura F Cavaliere F Quenet M Gutman AA Tentes G Lorimier JL Bernard JM Bereder J Porcheron A Gomez-Portilla P Shen M Deraco P Rat 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol. 22 3284 3292 15310771 10.1200/JCO.2004.10.012 1:STN:280:DC%2BD2cvgs1Giuw%3D%3D
11. D Elias F Gilly F Boutitie F Quenet JM Bereder B Mansvelt G Lorimier P Dubè O Glehen 2010 Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol. 28 63 68 19917863 10.1200/JCO.2009.23.9285
12. TC Chua DL Morris J Esquivel 2010 Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol. 17 1330 1336 20033321 10.1245/s10434-009-0866-x
13. F Cavaliere M De Simone S Virzì M Deraco CR Rossi A Garofalo F Di Filippo D Giannarelli M Vaira M Valle P Pilati P Perri M La Pinta I Monsellato F Guadagni 2011 Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O Eur J Surg Oncol. 37 148 154 21093205 10.1016/j.ejso.2010.10.014 1:STN:280:DC%2BC3M7lt1SrtA%3D%3D
14. O Glehen FN Gilly F Boutitie JM Bereder F Quenet L Sideris B Mansvelt G Lorimier S Msika French Surgical Association 2010 Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients Cancer. 116 5608 5618 20737573 10.1002/cncr.25356
15. PA Clavien JR Sanabria SM Strasberg 1992 Proposed classification of complications of surgery with examples of utility in cholecystectomy Surgery. 111 518 526 1598671 1:STN:280:DyaK383osFygsA%3D%3D
16. L Feldman J Barkun A Barkun J Sampalis L Rosenberg 1997 Measuring postoperative complications in general surgery patients using an outcomes based strategy: comparison with complications presented at morbidity and mortality rounds Surgery. 122 711 719 9347847 10.1016/S0039-6060(97)90078-7 1:STN:280:DyaK1c%2FgslGgtQ%3D%3D
17. D Elias T Matsuhisa L Sideris G Liberale L Drouard-Troalen B Raynard M Pocard JM Puizillou V Billard P Bourget M Ducreux 2004 Heated intraoperative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance Ann Oncol. 15 1558 1565 15367418 10.1093/annonc/mdh398 1:STN:280: DC%2BD2cvlvVKjug%3D%3D
18. F Bozzetti M Braga L Gianotti C Gavazzi L Mariani 2001 Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial Lancet 358 1487 1492 11705560 10.1016/S0140-6736(01)06578-3 1:STN:280:DC%2BD3MnltFKqsg%3D%3D
19. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO; 1979.
20. S Kusamura D Baratti R Younan B Laterza GD Oliva P Costanzo M Favaro C Gavazzi F Grosso M Deraco 2007 Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity Ann Surg Oncol. 14 9 2550 2558 17558537 10.1245/s10434-007-9429-1
21. VJ Verwaal H van Tinteren SV Ruth FA Zoetmulder 2004 Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol. 85 61 67 14755505 10.1002/jso.20013
22. O Glehen D Osinsky E Cotte F Kwiatkowski G Freyer S Isaac V Trillet-Lenoir AC Sayag-Beaujard Y Francois J Vignal FN Gilly 2003 Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol. 10 863 869 14527903 10.1245/ASO.2003.01.018 1:STN:280:DC%2BD3svmsFGhug%3D%3D
23. AD Stephens R Alderman D Chang GD Edwards J Esquivel G Sebbag MA Steves PH Sugarbaker 1999 Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique Ann Surg Oncol. 6 8 790 796 10622509 10.1007/s10434-999-0790-0 1:STN:280:DC%2BD3c%2Fos1ahsw%3D%3D
24. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Learning curve of combined modality treatment in peritoneal surface disease Br J Surg. 94 11 1408 1414 17631678 10.1002/bjs.5863 1:CAS:528:DC%2BD2sXhsVGitbbO
25. López-Basave HN, Morales-Vásquez F, Ruiz Molina JM, González-Enciso A, Namendys-Silva SA, Medina Castro JM, Montalvo-Esquivel G, Herrera-Gómez A, De la Garza Salazar JG. Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico. ISRN Oncol. 2011;2011:526384. Epub 2011 Aug 3.